GURUGRAM: Samsung is importing one million innovative Low Dead Space (LDS) syringes to support India’s Covid vaccination drive. This is part of the company’s Covid Support program for the country.
LDS syringes are said to minimise the amount of drug left in the syringes after an injection, reducing vaccine wastage, and thereby enabling 20% more people to get the dose with the same amount of vaccine.
Airlifted from South Korea, LDS syringes have been delivered in Uttar Pradesh (325,000 each to the district administrations in Lucknow and Noida) while 350,000 LDS syringes will soon be handed over to the Greater Chennai Corporation in Tamil Nadu. These syringes will be deployed at Covid Vaccination Centres in these districts.
The technology behind LDS syringes has demonstrated up to 20% greater efficiency. That means if existing syringes were to deliver one million doses, LDS syringes could deliver 1.2 million doses with the same amount of vaccine. Samsung has helped the manufacturer of these syringes increase production capacity.
This syringe has been introduced for usage in some other markets as well including the United States to optimize vaccination.
“Samsung stands strong with the nation in these testing times. Over the past few weeks, Samsung has focused on providing support to governments with Oxygen Concentrators and Oxygen Cylinders, and financial grants to purchase more of these equipment, as this was the need of the hour. Now, as our country focusses on vaccinating the population, we are supporting this effort with innovative LDS syringes that will help reduce vaccine wastage and vaccinate more people with the same amount of vaccine,” said Partha Ghosh, vice president and head of CSR, Samsung India.